These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31703893)

  • 1. Synthesis of benzopyran derivatives as PPARα and/or PPARγ activators.
    Bermejo A; Barrachina I; El Aouad N; Franck X; Chahboune N; Andreu I; Figadère B; Vila L; Hennuyer N; Staels B; Dacquet C; Caignard DH; Sanz MJ; Cortes D; Cabedo N
    Bioorg Med Chem; 2019 Dec; 27(24):115162. PubMed ID: 31703893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological studies of "Polycerasoidol" and "trans-δ-Tocotrienolic acid" derivatives as PPARα and/or PPARγ agonists.
    Vila L; Cabedo N; Villarroel-Vicente C; García A; Bernabeu Á; Hennuyer N; Staels B; Franck X; Figadère B; Sanz MJ; Cortes D
    Bioorg Med Chem; 2022 Jan; 53():116532. PubMed ID: 34863066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycerasoidol, a Natural Prenylated Benzopyran with a Dual PPARα/PPARγ Agonist Activity and Anti-inflammatory Effect.
    Bermejo A; Collado A; Barrachina I; Marqués P; El Aouad N; Franck X; Garibotto F; Dacquet C; Caignard DH; Suvire FD; Enriz RD; Piqueras L; Figadère B; Sanz MJ; Cabedo N; Cortes D
    J Nat Prod; 2019 Jul; 82(7):1802-1812. PubMed ID: 31268307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzopyran hydrazones with dual PPARα/γ or PPARα/δ agonism and an anti-inflammatory effect on human THP-1 macrophages.
    García A; Vila L; Duplan I; Schiel MA; Enriz RD; Hennuyer N; Staels B; Cabedo N; Cortes D
    Eur J Med Chem; 2024 Feb; 265():116125. PubMed ID: 38185055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
    Matin A; Gavande N; Kim MS; Yang NX; Salam NK; Hanrahan JR; Roubin RH; Hibbs DE
    J Med Chem; 2009 Nov; 52(21):6835-50. PubMed ID: 19807106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of a series of benzopyran derivatives as PPAR alpha/gamma agonists.
    Yu J; Tang L; Yang Y; Ji R
    Eur J Med Chem; 2008 Nov; 43(11):2428-35. PubMed ID: 18329751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor alpha and gamma.
    Rau O; Syha Y; Zettl H; Kock M; Bock A; Schubert-Zsilavecz M
    Arch Pharm (Weinheim); 2008 Mar; 341(3):191-5. PubMed ID: 18275039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a new 2-prenylated quinoline as potential drug for metabolic syndrome with pan-PPAR activity and anti-inflammatory effects.
    Villarroel-Vicente C; García A; Zibar K; Schiel MA; Ferri J; Hennuyer N; Enriz RD; Staels B; Cortes D; Cabedo N
    Bioorg Med Chem Lett; 2024 Jul; 106():129770. PubMed ID: 38677560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 2-Prenylated Alkoxylated Benzopyrans by Horner-Wadsworth-Emmons Olefination with PPARα/γ Agonist Activity.
    García A; Vila L; Marín P; Bernabeu Á; Villarroel-Vicente C; Hennuyer N; Staels B; Franck X; Figadère B; Cabedo N; Cortes D
    ACS Med Chem Lett; 2021 Nov; 12(11):1783-1786. PubMed ID: 34795868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel structural class of coumarin-chalcone fibrates as PPARα/γ agonists with potent antioxidant activities: Design, synthesis, biological evaluation and molecular docking studies.
    Niu H; Wang W; Li J; Lei Y; Zhao Y; Yang W; Zhao C; Lin B; Song S; Wang S
    Eur J Med Chem; 2017 Sep; 138():212-220. PubMed ID: 28667876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro and in silico evaluation of l-tyrosine containing PPARalpha/gamma dual agonists.
    Kumar R; Ramachandran U; Khanna S; Bharatam PV; Raichur S; Chakrabarti R
    Bioorg Med Chem; 2007 Feb; 15(3):1547-55. PubMed ID: 17166722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists.
    Kuhn B; Hilpert H; Benz J; Binggeli A; Grether U; Humm R; Märki HP; Meyer M; Mohr P
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4016-20. PubMed ID: 16737814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone.
    Wang XJ; Zhang J; Wang SQ; Xu WR; Cheng XC; Wang RL
    Drug Des Devel Ther; 2014; 8():2255-62. PubMed ID: 25422585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation.
    Ye XY; Chen S; Zhang H; Locke KT; O'Malley K; Zhang L; Srivastava R; Miao B; Meyers D; Monshizadegan H; Search D; Grimm D; Zhang R; Lippy J; Twamley C; Muckelbauer JK; Chang C; An Y; Hosagrahara V; Zhang L; Yang TJ; Mukherjee R; Cheng PT; Tino JA
    Bioorg Med Chem Lett; 2010 May; 20(9):2933-7. PubMed ID: 20356736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Oxazolidinone-Based Peroxisome Proliferator Activated Receptor Agonists: Molecular Modeling, Synthesis, and Biological Evaluation.
    Fresno N; Macías-González M; Torres-Zaguirre A; Romero-Cuevas M; Sanz-Camacho P; Elguero J; Pavón FJ; Rodríguez de Fonseca F; Goya P; Pérez-Fernández R
    J Med Chem; 2015 Aug; 58(16):6639-52. PubMed ID: 26226490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of dual PPARα/γ agonists and their effects on lipid metabolism.
    Gao Q; Hanh J; Váradi L; Cairns R; Sjöström H; Liao VW; Wood P; Balaban S; Ong JA; Lin HY; Lai F; Hoy AJ; Grewal T; Groundwater PW; Hibbs DE
    Bioorg Med Chem; 2015 Dec; 23(24):7676-84. PubMed ID: 26616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7-Hydroxy-2-substituted-4-H-1-benzopyran-4-one derivatives as aldose reductase inhibitors: a SAR study.
    Costantino L; Del Corso A; Rastelli G; Petrash JM; Mura U
    Eur J Med Chem; 2001 Sep; 36(9):697-703. PubMed ID: 11672879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARalpha and PPARgamma agonist activity.
    Fracchiolla G; Lavecchia A; Laghezza A; Piemontese L; Trisolini R; Carbonara G; Tortorella P; Novellino E; Loiodice F
    Bioorg Med Chem; 2008 Nov; 16(21):9498-510. PubMed ID: 18835719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part I: synthesis and pharmacological evaluation.
    Parmenon C; Guillard J; Caignard DH; Hennuyer N; Staels B; Audinot-Bouchez V; Boutin JA; Dacquet C; Ktorza A; Viaud-Massuard MC
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1617-22. PubMed ID: 18255290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoline-based derivatives of pirinixic acid as dual PPAR alpha/gamma agonists.
    Popescu L; Rau O; Böttcher J; Syha Y; Schubert-Zsilavecz M
    Arch Pharm (Weinheim); 2007 Jul; 340(7):367-71. PubMed ID: 17610302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.